Reclaim the Tumor Microenvironment via “Immunoforming”
Quadrant BioSciences Develops Saliva Tests to Detect Brain Diseases and Injuries
Cell Line Validation in Biomanufacturing
Confirming Identity, Purity, Sterility, and Functionality of Cell Lines Helps Keep Patients Safe
Cannabinoid-Based Drugs Seek New High, Part I
Developers Anticipate Additional Approvals after FDA Nod for Epidiolex
Top 10 Biopharma IPOs of January—June 2018
Number of Companies Going Public, and the Amount They Raise, Show Growth
For full access to this article login to GEN Select now.
Fine-Tuning the Design of GPCR Therapeutics
Understanding Allosteric Modulation and Functional Selectivity Are Key Priorities
- Bryan Roth, M.D., Ph.D., director of the National Institute of Mental Health’s psychoactive drug screening program at the University of North Carolina, suggests that the information printed in textbooks of pharmacology is “far from reality.” He is referring to recent discoveries about the incredible complexity of GPCR, the theme ...
Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.
Get GEN Select Access Now
- Do not put any letters or characters here if you are not a spy program.